The "New" Prostate Cancer InfoLink Social Network
A Service of Prostate Cancer International
Everolimus (Afinitor) trial
I am seeking to enter a clinical trial of everolimus (afinitor, target mTOR, kimase inhibior), a new drug effective in advanced kidney cancer
does anybody have information or opinion as to its use in prostate cancer
jj
does anybody have information or opinion as to its use in prostate cancer
jj
Replies to This Discussion
-
Permalink Reply by E. Michael D. ("Mike") Scott on -
Jena-Jacques:
See the following:
-- http://www.ncbi.nlm.nih.gov/pubmed/18361409
-- Approved US product web site for Afinitor
Clinical data on the use of everolimus in prostate cancer is very limited at this time. However, there are about a dozen different trials either ongoing or recrioting patients at the present time.
About
Selected Papers
Need InfoLink cards?
GENERAL DISCLAIMER
The "New" Prostate Cancer InfoLink's Social Network is intended for informational and educational purposes only. It is not engaged in rendering medical advice or professional services.
Any person who appears to knowingly render medical advice or promote a professional or commercial service on this site may be removed by the administrators without notice.
Information provided on this site should not be used for diagnosing or treating any health problem or disease.
The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your health care provider.
Any person who appears to knowingly render medical advice or promote a professional or commercial service on this site may be removed by the administrators without notice.
Information provided on this site should not be used for diagnosing or treating any health problem or disease.
The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your health care provider.
Events
© 2009 Created by Arnon Krongrad, MD on Ning. Create a Ning Network!
